What QUESTCOR PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Broadwood PARTNERS, L.p. | Director | Aug 14 | Disposition to Issuer · D | −11,683 | — | — | 0 |
| Broadwood PARTNERS, L.p. | Director | Aug 14 | Other Transaction · J | +0 | — | — | 0 |
| Broadwood PARTNERS, L.p. | Director | Aug 14 | Other Transaction · J | −1,818,248 | — | — | 0 |
| Silverman Lou | Director | Aug 14 | Disposition to Issuer · D | −24,183 | — | — | 0 |
| Young David | Chief Scientific Officer | Aug 14 | Disposition to Issuer · D | −14,000 | — | — | 0 |
| Young David | Chief Scientific Officer | Aug 14 | Disposition to Issuer · D | −32,750 | — | — | 0 |
| Young David | Chief Scientific Officer | Aug 14 | Disposition to Issuer · D | −70,991 | — | — | 0 |
| Furey Raymond J. | See Remarks | Aug 14 | Disposition to Issuer · D | −5,000 | — | — | 0 |
| Furey Raymond J. | See Remarks | Aug 14 | Disposition to Issuer · D | −25,250 | — | — | 0 |
| Furey Raymond J. | See Remarks | Aug 14 | Disposition to Issuer · D | −15,000 | — | — | 0 |
| Asarpota Rajesh | Sr. VP., CFO and PAO | Aug 14 | Disposition to Issuer · D | −4,000 | — | — | 0 |
| Asarpota Rajesh | Sr. VP., CFO and PAO | Aug 14 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Russell Angus C. | Director | Aug 14 | Disposition to Issuer · D | −3,835 | — | — | 0 |
| Russell Angus C. | Director | Aug 14 | Disposition to Issuer · D | −4,529 | — | — | 0 |
| Mulroy Michael H. | EVP, Strat. Affairs & GC | Aug 14 | Disposition to Issuer · D | −18,000 | — | — | 0 |
| Mulroy Michael H. | EVP, Strat. Affairs & GC | Aug 14 | Disposition to Issuer · D | −39,187 | — | — | 0 |
| Mulroy Michael H. | EVP, Strat. Affairs & GC | Aug 14 | Disposition to Issuer · D | −16,072 | — | — | 0 |
| Farrell Stephen C | Director | Aug 14 | Disposition to Issuer · D | −11,683 | — | — | 0 |
| Thompson Virgil D | Director | Aug 14 | Disposition to Issuer · D | −29,867 | — | — | 0 |
| Martin G. Kelly | Director | Aug 14 | Disposition to Issuer · D | −2,812 | — | — | 0 |
Loading...
